After two years of virtual conferences, a much-anticipated in-person J.P. Morgan Healthcare Conference was recently held in San Francisco. The world has adapted to virtual conferences due to the pandemic, but nothing can compare to the energy and excitement of an in-person gathering.
The great city of San Francisco greeted us with typical January weather, mildly chilly, with plenty of rain. The city was a buzz as the much-anticipated, first in-person conference after two years of virtual conferences had finally arrived, and attendees were excited to be back. Even though it seemed crowded, the number of participants was lower than expected, likely due to lingering concerns about the pandemic and overall safety challenges in San Francisco. Many may still be wary of attending large gatherings due to concerns about the ongoing pandemic. However, the fact that people are starting to attend events in-person again is a positive sign that the world is slowly returning to normalcy.
The global economy faces numerous challenges and risks, including supply chain issues, the war in Ukraine and a general slowdown of the economy. Despite these challenges, the healthcare industry remains much more robust than the economy in general. As a result, most industry leaders still expect growth in 2023.
Although revenue from COVID-related testing is decreasing, the positive outlook for the healthcare industry allows for continued investment in growth through internal innovation and acquisitions. Industry leaders have strong product pipelines, which is promising for the entire industry and its patients.
There are also some interesting industry trends to keep an eye on. One of these trends is increased multiplexing to test for more markers in shorter times. This will allow for more efficient and accurate testing, positively impacting patient care. Another trend is the increase in sensitivity, which means that tests can detect smaller amounts of a substance, making them more accurate.
Another significant trend is the move toward testing closer to the patient, even extending to the health-fitness-gadget industry. This trend will make it easier for patients to access testing and healthcare services, which can ultimately improve patient outcomes.
In conclusion, after two years of virtual conferences, the recent in-person conference is a positive sign that the world is slowly returning to normalcy. Despite the ongoing challenges faced by the global economy, the healthcare industry remains robust, and most industry leaders expect growth in 2023. There are also exciting industry trends to watch out for, including increased multiplexing, sensitivity and a move toward testing closer to the patient. All of these developments bode well for the healthcare industry and its patients.
Simon Langhart
Head of Sales & Marketing